Pharmaceuticals & Biotechnology

Sun Pharmaceutical Industries Limited

ISIN: INE044A01036 · Data as of Oct 2026
Share: WhatsApp ✕ X
Search another stock:
Active Funds Holding
233
vs Last Month
-16 funds
Total Value
₹34,488.59 Cr
Avg Weight
13.04%
New Entries
13
Exits
29
ℹ️ Index funds and ETFs are excluded. Only actively managed funds reflect genuine fund manager decisions.
Large Cap Rank #13
₹2.37 L Cr
Avg Mkt Cap · Jan-Jun 2023 (3yr ago)
→
₹4.22 L Cr
Avg Mkt Cap · Jan-Jun 2026 (latest)
+77.7%
3yr change
SEBI · AMFI Market Cap List
📋 What Changed This Month Sun Pharmaceutical Industries Limited is currently held by 233 active mutual funds with total exposure of ₹34,488.59 Cr. This month 13 funds entered and 29 funds exited. Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option has the highest allocation at 1155%. ↓ Scroll down for full fund list and monthly changes.
Trend

How Has Fund Coverage Changed — Last 5 Months?

Month Funds AUM (Cr) AMCs Status
Oct 2026 REFERENCE 233 ₹34,489 48 / 49
Sep 2026 249 ₹37,998 49 / 49 ✅ Complete
Aug 2026 242 ₹38,189 49 / 49 ✅ Complete
Jul 2026 250 ₹37,474 49 / 49 ✅ Complete
Jun 2026 247 ₹35,899 49 / 49 ✅ Complete

📌 Portfolio changes below are based on Oct 2026 data — the most complete month with 48 AMCs we cover uploaded.

This Month

What Changed in the Portfolio — Oct 2026?

Note: Index funds and ETFs are excluded from this analysis. Their holdings change due to index rebalancing, not active fund manager decisions, and do not reflect genuine conviction buys or exits.

By Category

Which Fund Categories Hold This Stock?

Category Funds Avg Weight Distribution
Equity 72 27.36%
Large Cap 23 10.67%
Flexi Cap 19 6.27%
Balanced Advantage 19 5.1%
Multi Asset 18 5.75%
ELSS 16 1.75%
Mid Cap 15 8.05%
Aggressive Hybrid 13 12.94%
Value/Contra 12 1.79%
Multi Cap 10 10.08%
Focused 9 3.15%
Dividend Yield 6 2.21%
Small Cap 1 23%
All Holdings

Which 233 Active Funds Hold Sun Pharmaceutical Industries Limited?

Filter:
Fund ↕ Category ↕ Weight ↕ Value ↕ Change ↕
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option
Nippon India Mutual Fund
Equity 1155% ₹1,049.97 Cr +1143.29%
Nippon India Active Momentum Fund-Direct Plan - Growth Option
Nippon India Mutual Fund
Equity 328% ₹19.91 Cr +324.56%
Nippon India Large Cap Fund - Direct Plan Growth Plan - Growth Option
Nippon India Mutual Fund
Large Cap 210% ₹1,094.06 Cr +207.82%
Nippon India Innovation Fund-Direct Plan-Growth Option
Nippon India Mutual Fund
Equity 188% ₹53.33 Cr +186.14%
Nippon India Aggressive Hybrid Fund - Direct Plan Growth Plan
Nippon India Mutual Fund
Aggressive Hybrid 150% ₹56.89 Cr +148.49%
Nippon India Vision Large & Mid Cap Fund - Direct Plan Growth Plan - Growth Option
Nippon India Mutual Fund
Mid Cap 105% ₹77.01 Cr +103.94%
Nippon India Flexi Cap Fund - Direct Plan - Growth Plan - Growth Option
Nippon India Mutual Fund
Flexi Cap 96% ₹86.52 Cr +95.24%
Nippon India Multi Cap Fund - Direct Plan Growth Plan - Growth Option
Nippon India Mutual Fund
Multi Cap 91% ₹476.45 Cr +90.09%
Nippon India Multi Asset Allocation Fund - Direct Plan - Growth Option
Nippon India Mutual Fund
Multi Asset 88% ₹159.44 Cr +87.25%
Nippon India Balanced Advantage Fund - Direct Plan Growth Plan - Growth Option
Nippon India Mutual Fund
Balanced Advantage 76% ₹71.90 Cr +75.23%
Nippon India Small Cap Fund - Direct Plan Growth Plan - Growth Option
Nippon India Mutual Fund
Small Cap 23% ₹177.77 Cr +22.78%
Nippon India Conservative Hybrid Fund - Direct Plan Growth Plan - Growth Option
Nippon India Mutual Fund
Equity 22% ₹2.10 Cr +21.78%
Kotak Healthcare Fund - Direct Plan - Growth Option
Kotak Mutual Fund
Equity 13.42% ₹115.55 Cr +0.21%
ITI Pharma and Healthcare Fund - Direct Plan - Growth Option
ITI Mutual Fund
Equity 11.67% ₹31.14 Cr -0.29%
Bandhan Healthcare Fund - Direct Plan - Growth
Bandhan Mutual Fund
Equity 11.48% ₹37.33 Cr +1.74%
Explore More
← Stock Search Top Stocks by MF Conviction Fund Directory AMC AAUM Rankings Market Cap Categories

Data source: Official AMFI monthly portfolio disclosures. Updated every month. Index funds and ETFs excluded. Disclaimer: This is not investment advice. Consult a SEBI-registered advisor before investing.